EUVIMEDDécouvrir EUVIMED
Open access · CC BY-NC-ND 4.0

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents

Bilal Ahmed Rizvi, Jonathan Kuziek, Lydia Y Cho, Paul E Ronksley, Melanie N Noel, Serena Laura Orr iD

Headache: The Journal of Head and Face Pain · 2024

DOI: 10.1111/head.14701 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, 2024. Written by Bilal Ahmed Rizvi and 5 co-authors. Institution: Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada. Major MEDLINE topics: Migraine Disorders, Depression, Anxiety. Cited 17 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Department of Pediatrics, Program of Undergraduate Research Experience, Alberta Children's Hospital Research Institute.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Objective

The objective of this study was to explore the longitudinal relationship between anxiety and depressive symptoms and migraine outcomes in children and adolescents.

Background

Children and adolescents with migraine experience more anxiety and depressive symptoms than their peers without migraine, but it is unknown if these symptoms are associated with differential migraine outcomes.

Methods

In this prospective clinical cohort study, children and adolescents aged 8.0–18.0 years with migraine completed headache questionnaires and validated measures of anxiety and depressive symptoms (Patient‐Reported Outcomes Measurement Information System) at an initial consultation and at their first follow‐up visit with a neurologist. Changes in monthly headache frequency and changes in migraine‐related disability (Pediatric Migraine Disability Assessment) were tracked at each time point. The relationships between these migraine outcomes and anxiety and depressive symptoms were estimated using models controlling for sex, age, headache frequency, and treatment type.

Results

There were 123 consenting participants. In models adjusted for age, sex, baseline disability score, and treatment type, baseline anxiety and depressive symptom levels were not significantly associated with change in headache frequency (for anxiety symptoms: β = −0.05, 95% confidence interval [CI] = −0.268 to 0.166, p = 0.639; for depressive symptoms: β = 0.14, 95% CI = −0.079 to 0.359, p = 0.209). Similarly, in models adjusted for age, sex, baseline headache frequency, and treatment type, the change in disability was not associated with baseline anxiety ( β = −0.45, 95% CI = −1.69 to 0.78, p = 0.470), nor with baseline depressive symptom scores ( β = 0.16, 95% CI = −1.07 to 1.40, p = 0.796). In post hoc exploratory analyses ( N = 84 with anxiety and N = 82 with depressive symptom data at both visits), there were also no significant associations between change in mental health symptoms and change in headache frequency (for anxiety symptoms: β = −0.084, 95% CI = −0.246 to 0.078, p = 0.306; for depressive symptoms: β = −0.013, 95% CI = −0.164 to 0.138, p = 0.865). Similarly, the change in disability scores between visits was not related to the change in anxiety ( β = 0.85, 95% CI = −0.095 to 1.78, p = 0.077) nor depressive symptom scores ( β = 0.32, 95% CI = −0.51 to 1.15, p = 0.446).

Conclusion

Baseline anxiety and depressive symptom levels were not associated with longitudinal migraine outcomes and neither were longitudinal changes in anxiety and depressive symptom levels; this contradicts popular clinical belief that mental health symptoms predict or consistently change in tandem with migraine outcomes.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersDepressionAnxietyHumansAdolescentMaleFemaleChildProspective StudiesLongitudinal Studies

Author keywords

anxietydepressionheadachemental healthmigrainepediatric

Authors and institutions

  • Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
  • Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID profiles: Serena Laura Orr

Funding

  • Department of Pediatrics
  • Program of Undergraduate Research Experience
  • Alberta Children's Hospital Research Institute
  • Department of Pediatrics, School of Medicine, University of Virginia

Cite

APA

Rizvi, B. A., Kuziek, J., Cho, L. Y., Ronksley, P. E., Noel, M. N., & Orr, S. L. (2024). Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14701

Vancouver

Rizvi BA, Kuziek J, Cho LY, Ronksley PE, Noel MN, Orr SL. Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents. Headache: The Journal of Head and Face Pain. 2024. doi:10.1111/head.14701

BibTeX
@article{Rizvi2024,
  author = {Rizvi, Bilal Ahmed and Kuziek, Jonathan and Cho, Lydia Y and Ronksley, Paul E and Noel, Melanie N and Orr, Serena Laura},
  title = {Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  doi = {10.1111/head.14701}
}
Start for free →